• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Merck starts $1 billion Biologics Center in Delaware, US

    PRESS RELEASE

    Keytruda improves survival in head and neck Cancer

    BUSINESSWIRE

    Halozyme sues Merck over subcutaneous Keytruda

    PRESS RELEASE

    Germany`s Merck in talks to buy SpringWorks for $3.5 billion

    REUTERS

    Merck CEO talks strategy amid tariff, policy uncertainty

    FIERCE PHARMA

    Merck Announces First-Quarter 2025 Financial Results

    BUSINESSWIRE

    Nissan Chemical extends supply deal with MSD Animal Health

    INDPHARMAPOST

    Merck links up with Cyprumed in $493M oral peptide deal

    FIERCE BIOTECH

    Cyprumed partners with MSD for oral peptide therapeutics

    GLOBENEWSWIRE

    Merck Ceo Rob Davis` 2024 Pay Climbed 13% To $23.2M

    FIERCE PHARMA

    Merck Manuals to Power Microsoft Copilot Health Agent

    PR NEWSWIRE

    Merck to Hold Q1 2025 Sales and Earnings Call on April 24

    BUSINESSWIRE

    Merck`s Winrevair cuts death, morbidity risk by 76%

    FIERCE PHARMA

    Merck Exercised Option for Global Rights of Abbisko`s Pimicotinib

    PR NEWSWIRE

    Merck plans to launch US subcutaneous version of Keytruda

    REUTERS

    Merck, Zebra Partner On Safety & Traceability Solutions

    INDPHARMAPOST

    EMA approves Merck`s Capvaxive for invasive pneumococcal disease

    INDPHARMAPOST

    Merck Commits Nearly $2B for Oral Lipid-Lowering Drug from Chinese Biotech

    BIOSPACE

    First Patient Dosed In Immutep’s Ph III NSCLC Trial

    GLOBENEWSWIRE

    Merck Data at ACC.25 Showcases Advancements in Cardiovascular

    BUSINESSWIRE

    Merck`s Biologic Keytruda Receives Approval in US

    FDA

    Merck: Positive Phase 3 Data on Doravirine/Islatravir HIV Regimen

    BUSINESSWIRE

    Merck opens $1B Gardasil manufacturing facility in North Carolina

    BUSINESSWIRE

    Merck prevails in US safety litigation over Gardasil HPV vaccine

    REUTERS

    Merck’s Injectable Keytruda Create Legal Dispute With Halozyme

    BIOSPACE

    IO Biotech Reports 2024 Business Highlights

    GLOBENEWSWIRE

    Merck nabs $30M from Delaware for potential facility

    FIERCE PHARMA

    Merck expects Keytruda to be part of government price

    REUTERS

    Medicenna Reports MDNA11’s Anti-Cancer Activity at AACR Conference

    GLOBENEWSWIRE

    FDA Grants Review To Merck’s Keytruda Combo For Head & Neck Cancer

    BUSINESSWIRE

    Merck to Participate in the TD Cowen Annual Health Care Conference

    BUSINESSWIRE

    Merck Plans Workforce Expansion in India

    ECONOMICTIMES

    Merck’s Welireg receives European approval for two indications

    PRESS RELEASE

    Radiance rolls into ROR1 race, paying $15M for ADC

    FIERCE BIOTECH

    Merck`s $300M-per-product collab with Epitopea to tumor antigens

    BIOSPACE

    Neuphoria To Receive $15M Milestone Payment From Merck

    GLOBENEWSWIRE

    Kineta sells Genentech, Merck deals to investor ahead of merger

    FIERCE BIOTECH

    Merck reports 2024 sales at $64.2 billion

    INDPHARMAPOST

    BioMed X, Merck Complete ecDNA Cancer Research Project

    CONTRACTPHARMA

    Merck Launches Phase 3 Trial for Zilovertamab Vedotin in DLBCL

    BUSINESSWIRE

    Merck halts Gardasil shipments to China, pulls $11B sales target

    FIERCE PHARMA

    Merck Canada Launches “Listen Close” Campaign for Lung Awareness

    BUSINESSWIRE

    Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results

    BUSINESSWIRE

    Merck Gets Positive CHMP Opinion For CAPVAXIVE In Adults

    BUSINESSWIRE

    Merck Halts Phase 3 HYPERION Trial For WINREVAIR Early

    BUSINESSWIRE

    Merck to stop lung condition drug study early due to strong data

    REUTERS

    Diatech, Merck Expand Collaboration In Middle East, Africa

    BUSINESSWIRE

    FDA Grants Priority Review To Merck’s WELIREG® For PPGL Treatment

    PHARMAWEB

    Merck Announces Q2 2025 Dividend & $10 Billion Share Repurchase

    BUSINESSWIRE

    FDA Grants Priority Review to Merck’s WELIREG for PPGL Treatment

    BUSINESSWIRE

    Merck inaugurates the expansion of its Peenya facility in Bengaluru

    EXPRESSPHARMA

    Merck inaugurates expansion of its Peenya facility in Bengaluru

    EXPRESSPHARMA

    Merck, Eisai combo misses survival goal in GI cancer trial

    FIERCE PHARMA

    Kennedy played key role in Gardasil vaccine case against Merck

    REUTERS

    Merck Sets Q4 And Full-Year 2024 Earnings Call For February 4

    BUSINESSWIRE

    Merck’s GARDASIL® Receives Expanded Approval for Males in China

    BUSINESSWIRE

    Merck`s HPV vaccine gets China approval for amid declining sales

    REUTERS

    WuXi Biologics to sell Irish vaccine site to Merck for $500M

    ENDPTS

    Merck to Participate in the 43rd Annual J.P. Morgan Conference

    BUSINESSWIRE

    Merck wins UK approval for lung disease drug acquired in $11 B deal

    REUTERS

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.